(Q24240010)

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Molecular keys to the problems of cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

The 2007 Feinberg lecture: a new road map for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Calcium antagonists for aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Effects of the 21-aminosteroid U74006F on experimental head injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Tirilazad for aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

Barbiturates for acute traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

7 January 2021

Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: I. Single-dose administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

7 January 2021

Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple-dose administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

7 January 2021

Metaanalysis of trials of tirilazad mesylate in aneurysmal SAH.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

7 January 2021

Effect of the nonglucocorticoid 21-aminosteroid U74006F experimental cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

7 January 2021

21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

7 January 2021

A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

7 January 2021

Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

7 January 2021

Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

7 January 2021

Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

7 January 2021

The role of active smooth-muscle contraction in the occurrence of chronic vasospasm in the canine two-hemorrhage model

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006778.PUB2

7 January 2021

10.1002/14651858.CD006778.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4366653

4366653

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference